New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 29, 2014
18:05 EDTZTSZoetis could climb 25%, Barron's says
Zoetis (ZTS) isn't subject to the same patent expiration cliff as Pfizer (PFE) and earnings should rise 13% over the next few years, Barron's says in its "Weekday Trader" column. Shares could climb 25%, the paper adds. Reference Link
News For ZTS From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
December 17, 2014
16:16 EDTZTSZoetis raises quarterly dividend by 15% to 8.3c
Subscribe for More Information
10:36 EDTZTSOptions with decreasing implied volatility
Subscribe for More Information
December 11, 2014
10:13 EDTZTSOn The Fly: Analyst Initiation Summary
Subscribe for More Information
07:12 EDTZTSZoetis initiated with a Market Perform at Cowen
Subscribe for More Information
December 9, 2014
11:19 EDTZTSSanofi reportedly ready to make acquisitions in animal medicine, Bloomberg says
Subscribe for More Information
09:31 EDTZTSZoetis drops after report of Valeant abandoning growth by acquisitions strategy
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use